Symptomatic malignant ascites drainage with a patient-controlled vascular catheter: interim analysis of safety and patient-reported outcomes
Supportive Care in Cancer · 2025
DOI: 10.1007/s00520-025-09265-4 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, 2025. Verfasst von Maciej Stukan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecological Oncology, Gdynia Oncology Center, Pomeranian Hospitals, Gdynia, Poland. maciej.stukan@gmail.com. Hauptthemen laut MEDLINE: Ascites, Drainage, Neoplasms, Central Venous Catheters. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Malignant ascites (MA) and repeated paracentesis can impair a patient's quality of life (QOL). The aim was to perform an interim analysis of safety and changes in patients' QOL in an ongoing prospective, multicentre (conducted within the Central and Eastern European Gynaecologic Oncology Group (CEEGOG)) trial on symptomatic MA drainage with a patient-controlled central vascular catheter (CVC) inserted into the abdominal cavity. CVC (14-Ga) was inserted into the abdominal cavity of patients with symptomatic MA, and drainage was controlled by patients at home. The rate and quality of complications were classified according to Common Terminology Criteria for Adverse Events Version 5.0. QOL was evaluated before and 10-14 days after/during drainage with standardized QLQ-C15-PAL, SGA, and FACIT-TS-G questionnaires. Wilcoxon and Chi-squared tests were used. Among 113 recruited patients (2015-2022), seven patients experienced complications (6.2%), and there was one patient with a serious adverse event (death on the 9th day after catheter insertion, classified as not related to the intervention). Adverse events included local infection (n = 2) (resolved after oral antibiotics), catheter obstruction (n = 2), catheter self-removal (n = 2) (re-insertion performed), and nausea (n = 1). When comparing the assessment before and after/during drainage, we found the significantly better global QOL (mean 31.8 vs. 47.8, p < 0.001), improvement in physical (52.6 vs. 64.4, p < 0.001) and emotional functioning (50.7 vs. 65.4, p < 0.001); symptoms were significantly less intense: fatigue (66.7 vs. 50.9, p < 0.001), nausea and vomiting (37.8 vs. 21.4, p < 0.001), pain (53.9 vs. 34.1, p < 0.001), dyspnoea (48.5 vs. 22.3, p < 0.001), insomnia (49.1 vs. 34.3, p < 0.001), appetite loss (56.3 vs. 40.3, p < 0.001), and constipation (31.0 vs. 25.2, p = 0.007), and more patients had no pain on eating (71.3% vs. 82.9%, p = 0.04). Most patients (78%) were satisfied, 83% would recommend the procedure to others, and 90% would choose intervention again. The interim analysis provided data on the safety and improvement of patients' QOL after MA drainage via patient-controlled CVC inserted into the abdominal cavity, thus justifying the continuation of recruitment for the main trial without changes in the protocol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecological Oncology, Gdynia Oncology Center, Pomeranian Hospitals, Gdynia, Poland. maciej.stukan@gmail.com.
- Surgical Oncology Clinic, Gdansk Medical University, Gdansk, Poland. maciej.stukan@gmail.com.
- Wroclaw Medical University, Wroclaw, Poland.
- Lower Silesian Oncology, Pulmonology and Hematology Center, Wroclaw, Poland.
- Department for Gynecological and Breast Oncology, UMC Maribor, Maribor, Slovenia.
- Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Czech Republic.
Zitieren
APA
Stukan, M., Jędryka, M., Cokan, A., Klát, J., Ndukwe, M. I., Kryszpin, M., Poblocka, R., Timošek, E., Romanová, M., Balcarová, K., Madry, R., & Cibula, D. (2025). Symptomatic malignant ascites drainage with a patient-controlled vascular catheter: interim analysis of safety and patient-reported outcomes. Supportive Care in Cancer. https://doi.org/10.1007/s00520-025-09265-4
Vancouver
Stukan M, Jędryka M, Cokan A, Klát J, Ndukwe MI, Kryszpin M, et al. Symptomatic malignant ascites drainage with a patient-controlled vascular catheter: interim analysis of safety and patient-reported outcomes. Supportive Care in Cancer. 2025. doi:10.1007/s00520-025-09265-4
BibTeX
@article{Stukan2025,
author = {Stukan, Maciej and Jędryka, Marcin and Cokan, Andrej and Klát, Jaroslav and Ndukwe, Munachiso Iheme and Kryszpin, Marcin and Poblocka, Renata and Timošek, Eva and Romanová, Martina and Balcarová, Klára and Madry, Radoslaw and Cibula, David},
title = {Symptomatic malignant ascites drainage with a patient-controlled vascular catheter: interim analysis of safety and patient-reported outcomes},
journal = {Supportive Care in Cancer},
year = {2025},
doi = {10.1007/s00520-025-09265-4}
}
EUVIMED